← Back to Search

Online Therapy with Coaching for Postpartum Depression

N/A
Recruiting
Research Sponsored by University of California, Los Angeles
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 26
Awards & highlights

Study Summary

This trial is investigating mood changes and risk factors for depression and anxiety in new moms, and treatment response around the time of delivery. Women with elevated symptoms can participate in treatment, which can last up to 6 months.

Who is the study for?
This trial is for English-speaking women between week 28 of pregnancy and 6 months postpartum, receiving care at a UCLA OB-GYN clinic, who are not currently in individual treatment for emotional problems but have moderate to severe depression symptoms. They must be willing to follow study procedures and have internet access.Check my eligibility
What is being tested?
The study tests mood changes and treatments around childbirth. Participants complete surveys, use an app for data collection, and may receive Perinatal Psychiatric Care or STAND (Screening/Treatment for Anxiety/Depression), which includes online therapy with coaching or clinical psychotherapy.See study design
What are the potential side effects?
Since the interventions involve psychiatric care and online therapy rather than medication, side effects might include discomfort from discussing personal issues or potential stress related to regular engagement with treatment protocols.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 26
This trial's timeline: 3 weeks for screening, Varies for treatment, and week 26 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change From Baseline in Computerized Adaptive Testing - Mental Health (CAT-MH) Scores At Post-Treatment and Week 26
Secondary outcome measures
Edinburgh Postnatal Depression Scale (EPDS-9)
Other outcome measures
Sheehan Disability Scale (SDS)

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Screening and Treatment of Anxiety and Depression (STAND)Experimental Treatment2 Interventions
This treatment condition provides access to a system of care, in which type of treatment is allocated based on presenting symptomatology. Participants will learn their allocation from study staff or participants will create a secure account through STAND to learn about their allocation through the STAND online dashboard. Through their STAND online dashboard, they could also have access to a) their CAT-MH results over time from the start of treatment, b) assessment of their current diet/nutrition and psychoeducation about the relationship between diet/nutrition and mental health, and c) list of additional resources available to them.
Group II: Treatment as usual (TAU, a.k.a. Perinatal Psychiatric Care)Active Control1 Intervention
This treatment condition is modelled after the psychiatry-delivered treatment usually provided at the Maternal Outpatient Mental Health Services (MOMS) Clinic associated with the UCLA Westwood OB-GYN Clinic and Department of Psychiatry.

Find a Location

Who is running the clinical trial?

University of California, Los AngelesLead Sponsor
1,530 Previous Clinical Trials
10,278,035 Total Patients Enrolled
2 Trials studying Postpartum Depression
231 Patients Enrolled for Postpartum Depression

Media Library

Clinical care Clinical Trial Eligibility Overview. Trial Name: NCT05056454 — N/A
Postpartum Depression Research Study Groups: Treatment as usual (TAU, a.k.a. Perinatal Psychiatric Care), Screening and Treatment of Anxiety and Depression (STAND)
Postpartum Depression Clinical Trial 2023: Clinical care Highlights & Side Effects. Trial Name: NCT05056454 — N/A
Clinical care 2023 Treatment Timeline for Medical Study. Trial Name: NCT05056454 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

To what extent is the current trial involving participants?

"Affirmative, the medical trial is presently enrolling individuals. This research endeavour was initially posted on April 15th 2021 and was last modified on May 16th 2022. The study requires 200 participants to be recruited from a single site."

Answered by AI

Who has the opportunity to volunteer for this clinical research?

"This clinical trial is currently enrolling two hundred individuals aged 18 to 65 who have been diagnosed with depression. In order for volunteers to be eligible, they must not already be in one-on-one treatment for a mental health or behavioural issue (e.g., anxiety), possess fluency in the English language, and own either a mobile phone or desktop computer that can access the internet. Furthermore, women between 28 weeks of gestation and 10 weeks postpartum receiving care at an UCLA OB-GYN clinic will qualify if their Edinburgh Postnatal Depression Scale score registers as moderate or higher (>11). All participants are expected to follow study protocols"

Answered by AI

Is participation in this medical trial restricted to individuals aged 18 or older?

"According to the eligibility requirements, applicants for this trial must be aged 18-65. For those under or over that range, 255 and 1186 trials respectively are available."

Answered by AI

Does this research endeavor currently have openings for participants?

"According to the available information on clinicaltrials.gov, this trial is recruiting new participants since its posting date of April 15th 2021 and last update on May 16th 2022."

Answered by AI
~9 spots leftby Jun 2024